ASSET PURCHASE AGREEMENT BY AND BETWEEN COHERUS BIOSCIENCES, INC., AND INTAS PHARMACEUTICALS LTD. DATED AS OF December 2, 2024Asset Purchase Agreement • December 3rd, 2024 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 3rd, 2024 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 2, 2024 by and among Coherus BioSciences, Inc., a Delaware corporation (“Seller”), and Intas Pharmaceuticals Ltd., a limited company incorporated in India (“Buyer”). Each of Seller and Buyer are referred to herein as a “Party” and together as the “Parties.” Capitalized terms used but not otherwise defined herein have the meanings set forth in Article I.